Case Conclusion Date: 09.30.2010
Practice Area: Consumer protection
Outcome: $410,000,000+ settlement
Description: Former Novartis sales representatives brought a qui tam case against Novartis for off-label marketing of anti-seizure drug Trileptal. After several years of investigation, Novartis agreed to pay more than $410 million to the U.S. and more than 20 states, and plead guilty to a federal criminal charge of illegal off-label marketing.